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license (http://creativecommons.org/Summary Background/Objective: Alpinia officinarum Hance (AOH) is a traditional herbal
medicine specific to south China and serves as a civil medication application of an antioxidant.
Growing evidence demonstrates that antioxidants are beneficial for the treatment of osteopo-
rosis. This study was designed to investigate the antiosteoporotic effects of total extracts from
AOH in ovariectomised (OVX) rats and the different fractions in AOH on primary osteoblasts ac-
tivities.
Methods: The total extract of AOH was extracted by refluxing using 95% ethanol, then the five
fractions (F1eF5) were separated from AOH using thin-layer chromatography according to po-
larity from high to low, and the galangin content was determined using high performance liquid
chromatography. In an in vivo study, 36 4-month-old female Sprague-Dawley rats were used as
a Sham-operated group, OVX with vehicle (OVX), OVX with epimedium flavonoids (EF, 150 mg/
kg/d), and OVX with AOH (AOH, 300 mg/kg/d), respectively. Daily oral administration started
on Day 3 after OVX and lasted for 12 weeks. In the in vitro study, primary osteoblasts were
incubated with AOH, galangin, and five different fractions (F1eF5) with or without hydrogen
peroxide (H2O2), respectively.ing Donglu, Xiashan District, Zhanjiang, Guangdong Province, People’s Republic of China.
L. Cui).
to this work.
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76Results: Treatment with AOH significantly attenuated osteopenia accompanied by a decreased
percentage of osteoclast perimeter and bone formation rate per unit of bone surface,
enhanced the bone strength, and prevented the deterioration of trabecular microarchitecture
associated with a decrease in biochemical parameters of oxidative stress. Furthermore, treat-
ment with AOH, F3, F4, and galangin increased cell viability, differentiation, and mineralisa-
tion in osteoblasts with or without H2O2 and rescued the deleterious effects of H2O2 on cell
apoptosis and intracellular reactive oxygen species level. The effects on osteoblast formation
were highly aligned with the amounts of flavonoids within AOH.
Conclusion: These data demonstrate that ethanol extracts from AOH significantly reverse bone
loss, partially by increasing bone formation, and by suppressing bone resorption associated
with antioxidant effects, suggesting that AOH can be developed as a promising agent for the
prevention and treatment of osteoporosis.
Copyright ª 2015, The Authors. Published by Elsevier (Singapore) Pte Ltd. This is an open ac-
cess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Osteoporosis is a progressive systematic disease charac-
terised by low bone mineral density (BMD) and deteriorated
microarchitecture of bone which leads to an increase in the
risk of fracture [1]. With the aging of the world’s popula-
tion, osteoporosis has become a serious global health
problem. Several drugs are used to reduce bone loss in
osteoporosis, including oestrogen, bisphosphonates, and
parathyroid hormone, and many studies show that long-
term use of these drugs might cause many adverse re-
actions, such as increasing the risk of endometrial and
ovarian cancer [2,3], atypical femoral fractures [4],
osteonecrosis of the jaw [5], venous thromboembolism [6],
and nervous system disorders [7]. Consequently, it is
necessary to develop an alternative with promising effi-
ciency and fewer undesirable side effects to prevent or
reverse postmenopausal osteoporosis.
Herbal medicine for the treatment of osteoporosis would
be advantageous because they have potentially fewer side
effects and multiple pharmacological actions on bone,
making them more suitable for long-term use [8,9]. A
number of medicinal herbs or natural compounds, such as
epimedium [10], icariin [11], resveratrol [12], Rhizoma
drynariae [13], and Salvia miltiorrhiza bunge [14], show
preventive effects on bone loss induced by oestrogen
deficiency, inflammation, or physical inactivity. They are
cost-effective with few side effects and target multiple
signalling pathways involved in bone metabolism [10e14].
Alpinia officinarum Hance (AOH) is a traditional herbal
medicine within a strict growing area and specifically grows
in south China. AOH is rich in bioactive phytochemical
compounds such as flavonoids, diarylheptanoids, and
essential oils, and it has been proven safe and is used for
the treatment of a variety of diseases for a long time in
China [15,16]. Many studies have shown that AOH presents
anti-inflammatory and antioxidative properties both
in vitro and in vivo [17e19]. AOH can exert an antiamnesiac
effect in Ab-induced neurodegeneration in mice through an
antioxidant property [19]. Flavonoids isolated from AOH
mainly consist of quercetin, kaempferol, and galangin,
which play a role in the protection against oxidative stressby promoting the expression of antioxidative proteins [20].
Furthermore, quercetin can promote osteoblast differen-
tiation and inhibit osteoclastogenesis via downregulation of
mRNA expression of the RANKL gene in osteoblasts and
subsequently inhibits osteoclastic function [21]. In addi-
tion, galangin, a flavonol derived from AOH, was proven to
exert strong antioxidative and radical scavenging effects
[22] and can reduce lipopolysaccharide-induced acute lung
injury [23], fructose-induced rat liver injury [24], and
fructose-induced rat kidney injury [25]. Moreover, galangin
can prevent osteoclastic bone destruction and inhibit
osteoclastogenesis via the attenuation of RANKL-induced c-
Jun N-terminal kinases, p38, and nuclear factor-kappaB
activation in osteoclast precursors as well as in collagen-
induced arthritis mice [26].
A growing number of researches showed that oxidative
stress is a pivotal reason for bone loss after the menopause
and age-related bone loss [27,28]. Oxidative stress has been
reported to inhibit osteoblastic differentiation and
decrease the life span of osteoblasts, and also increase
bone resorption by enhancing osteoclastic development
and activity [29], thus, leading to a shift towards bone
absorption more than bone formation, resulting in osteo-
porosis [30]. Antioxidant agents are beneficial for the
treatment of osteoporosis by increasing bone formation or
suppressing bone resorption [31,32]. Therefore, AOH with
an antioxidative capacity may be developed as a novel
agent for the prevention and treatment of osteoporosis.
The present study was conducted to investigate the bone
effects of AOH in ovariectomised (OVX) rats and to estimate
different fraction compounds from AOH on the differenti-
ation and antioxidative activities in primary osteoblasts
in vitro.Materials and methods
Preparation of total extract and five fractions
(F1eF5) of AOH
The dried AOH was collected from Xuwen country, Guang-
dong, China. AOH (36 kg) was crushed into coarse power,
Figure 1 High performance liquid chromatography chro-
matograms of galangin, Alpinia officinarum Hance, and five
fractions (F1eF5). X-axis is retention time (min). Y-axis is
absorbance unit (mAU). AOH Z Alpinia officinarum Hance.
Antiosteoporotic effects of Alpinia Officinarum 77and then extracted six times with 98% ethanol. Afterwards,
the leaching solution was collected and concentrated by
evaporation to obtain the total extract of AOH to be used in
the following steps. Then, AOH was further separated and
purified with an ethyl acetate-petroleum ether (64:36)
system, containing 2% acetic acid, and the extracts were
separated into five fractions (F1eF5) according to the range
from high to low polarity. The quality of the five fractions
(F1eF5) was controlled by using thin layer chromatography
and high performance liquid chromatography (HPLC). The
chromatographic separation was achieved at 30C on a
Phenomenex C18 (Ø 250 mm  4.6 mm, Agilent series 1100;
Phenomenex Inc., Torrance, CA, USA) column. The run time
was set at 40 minutes. The flow rate was 1.0 mL/min. The
sample injection volume was 20 mL. The mobile phase was
acetonitrile-0.2% H3PO4 solution (48:52). Galangin, as an
ingredient of the extract, was purchased from the National
Institutes for Food and Drug Control (Beijing, China).
Animals
Thirty-six 4-month-old virgin female SpragueeDawley rats
(obtained from the Centre of Experiment Animal of Sun Yat-
sen University Ltd., Guangzhou, Guangdong, China)
weighing 265  14 g were used in this experiment [33]. All
animals were acclimatised to local vivarium conditions
(temperatures ranged from 24C to 26C, with a humidity
level of 70%). During the experimental period, the rats were
maintained on standard chow containing 1.33% calcium and
0.95% phosphate, and distilled water available ad libitum.
The animals were treated in accordance with the Guide for
Care and Use of Laboratory Animals by the National Com-
mittee of Science and Technology of China. The experi-
mental protocol was approved by the institutional animal
use and care review board of Guangdong Medical Univer-
sity, Zhanjiang, China.
Surgery and treatments
The acclimatised rats underwent either bilateral sham
operation (SHAM, n Z 8) or bilateral ovariectomy (OVX,
n Z 24, three groups with 8 rats/group) under general
anaesthesia by 1% pentobarbital as previously described
[34,35]. The OVX rats were then treated with a vehicle
(OVX), epimedium flavonoids (EF, 150 mg/kg/d), or AOH
(AOH, 300 mg/kg/d). EF was obtained from Xi’an Pulaite
Biological Bioengineering Co., Xi’an, ShanXi, China. All
treatments were performed by daily oral gavage from the
3rd day after surgery for 12 weeks. According to the Human
Rat Equivalent Dose Conversion Principle [36,37] and the
Chinese Pharmacopoeia, the experimental dose for AOH in
the present study was equivalent to the corresponding
clinical prescription dose for a 60-kg human participant. The
experimental dose for epimedium flavonoids (150 mg/kg/d)
in the present study was according to the previous study
[38]. The body weight of rats was recorded weekly. All rats
received a subcutaneous injection of calcein (10 mg/kg;
Sigma Chemical Co., St. Louis, MO, USA) on Day 3, Day 4, Day
13, and Day 14 before sacrifice for in vivo double labelling.
At the endpoint, rats were anaesthetised with sodium
pentobarbital (50 mg/kg intraperitoneally; Sigma Chemical
Table 1 Content of galangin in Alpinia officinarum Hance and five fractions (F1eF5).
Fractions AOH F1 F2 F3 F4 F5
Percentage of galangin 0.519  0.008 0.092  0.004 0.384  0.008 24.443  0.087 0.191  0.007 0.042  0.0 03
Data are presented as mean  standard deviation.
AOH Z Alpinia officinarum Hance.
Figure 2 Effects of Alpinia officinarum Hance on (A) body
weight and (B) uterus index in ovariectomised rats. Data are
given as mean  standard deviation. *p < 0.05 versus SHAM.
**p < 0.05 versus ovariectomised rats as evaluated by analysis
of variance. SHAM Z rats that underwent bilateral sham
operation; OVX Z rats that underwent bilateral ovariectomy
and treated with vehicle; EF Z rats that underwent bilateral
ovariectomy and treated with epimedium flavonoids; AOH Z
rats that underwent bilateral ovariectomy and treated with
Alpinia officinarum Hance.
78Co.) and euthanised. Blood and the right tibiae were
collected for biochemical measurements. The uterus was
collected and weighed. Left femurs and the fifth lumbar
were dissected and stored at 20C for measurement of
bone mineral content (BMC) and BMD using dual-energy X-
ray absorptiometry (DXA). Left femurs were collected for
microcomputed tomography (mCT) analysis and followed by
a three-point bending test. The left tibia was collected for
bone histomorphometry. Right femurs were decalcified for
histology and terminal deoxynucleotidyl transferase dUTP
nick end labeling (TUNEL) assay.
Biochemical assays
Venus blood was collected and transferred to a centrifuge
tube. Serum was prepared by centrifuging at 3000g for
10 minutes and stored at 80C. The right tibia was washed
to allow for bone marrow collection. Serum malondialde-
hyde (MDA), serum superoxide dismutase (SOD), and bone
glutathione reductase (GSR) were measured using com-
mercial kits and all procedures were performed according
to the manufacturers’ instruction (Nanjing Jiancheng Bio-
logical Bioengineering Co., Nanjing, China). An automatic
plate reader (BioTek Instruments Inc., Winooski, VT, USA)
was introduced to the measurements. Part of the bone
marrow was centrifuged to obtain bone marrow cells.
These cells were then labelled with 20,7’-dichlor-
fluorescein-diacetate (20M) for 30 minutes at 37C and
followed by measurement of fluorescence intensity using
BD FACSCalibur flow cytometry (BD Biosciences, San Jose,
CA, USA) [39]. Data were analysed and acquired using
CellQuest Pro software (BD Biosciences).
DXA analysis
Two-dimensional BMC and BMD of the left femur and the
fifth lumbar were measured using Lunar Prodigy Advance
with a DXA scanner (GE Lunar Pharmalegacy Co., Fairfield,
CT, USA) as previously described [40]. BMD was calculated
by BMC of the measured area.
mCT analysis
Femurs were collected and performed in trabecular
microarchitecture using a viva CT40 (Scanco Medical,
Bruttisellen, Switzerland) in high resolution condition (X-
ray energy 70KVp, 114Ma, 8W; integration time 200 msec;
average data on 1) as reported elsewhere [41]. The femur
was scanned from the distal growth plate to the proximal
direction (18 mm/slice). To avoid primary spongiosa, the
measurement site on the bone sections was the distal
femur between 1 mm and 4 mm (160 slices) distal to the
growth plate-epiphyseal junctions. Cortical bone analysiswas performed on a 1-mm region of interest from 7 mm
(370 slices) distal to the growth plate-epiphyseal junctions.
A threshold value of 200 was used to separate the trabec-
ular bone from cortical bone in the analysis system in order
to construct a three-dimensional image of the trabecular
and cortical bone. After reconstruction, the following pa-
rameters were measured: relative bone volume to total
volume (BV/TV), trabecula number (Tb.N), trabecula sep-
aration (Tb.Sp), trabecula thickness (Tb.Th), structure
model index (SMI), connectivity density (Conn.D), cortical
area (Ct.Ar), and cortical thickness (Ct.Th).
Bone histomorphometry
The left tibias were removed and bone marrow cavities
were exposed using a Low Speed Saw (Buehler Ltd., Chi-
cago, IL, USA). The proximal tibial metaphyses were fixed in
10% buffered formalin for 24 hours followed by gradient
Table 2 Effects of Alpinia officinarum Hance on biochemical markers of the blood and bone in ovariectomised rats.
Parameter SHAM OVX EF AOH
Serum SOD (U/mL) 94.61  27.18 41.46  5.97* 70.95  23.96** 81.40  6.77**
Serum MDA (mmol/L) 5.21  2.08 15.64  1.95* 9.59  0.86** 5.89  1.40**
Bone ROS (AFU  1000) 1.17  0.46 3.96  0.78* 2.33  0.52*,** 2.08  0.27*,**
Bone GSR (mU/min/mg protein) 1.67  0.31 0.30  0.06* 1.08  0.24*,** 0.81  0.21*,**
Data are presented as mean  standard deviation.
*p < 0.05 versus SHAM.
**p < 0.05 versus ovariectomised rats as evaluated by analysis of variance.
SHAMZ rats that underwent bilateral sham operation; OVXZ rats that underwent bilateral ovariectomy and treated with vehicle; EFZ
rats that underwent bilateral ovariectomy and treated with epimedium flavonoids; AOH Z rats that underwent bilateral ovariectomy
and treated with Alpinia officinarum Hance; SOD Z superoxide dismutase; MDA Z malondialdehyde; ROS Z reactive oxygen species;
GSR Z glutathione reductase.
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embedded undecalcified in methyl methacrylate. The
proximal tibial metaphysis was cut at a thickness of 9 mm
and 5 mm with RM2155 hard tissue microtome (Leica AG,
Wetzlar, Germany). The 9-mm unstained sections were used
for dynamic histomorphometric analyses. The 5-mm sec-
tions were used for toluidine blue staining and Masson-
Goldner Trichrome staining for the static histomorpho-
metric measurements. A semiautomatic digitising image
analysis system (Osteometrics, Atlanta, GA, USA) was used
for quantitative bone histomorphometric measurements.
The following parameters were measured: Tb.N, Tb.Sp,
percent of osteoclasts perimeter (%Oc.Pm), bone formation
rate per bone surface (BFR/BS), percent of the trabecular
bone area (%Tb.Ar), percent of osteoblasts perimeter (%
Ob.Pm), number of osteoclasts (Oc.N), and percent of
labelled perimeter (%L.Pm).
Three-point bending test
Femurs were collected and bone biomechanical tests were
performed on them using the 858 Mini Bionix material
testing machine (MTS, Eden Prairie, MN, USA). Femurs were
positioned horizontally with the anterior surface upwards
and centred on the supports 10 mm apart. A displacement
rate of 5 mm/min was selected for applying the loading
vertically to the midshaft with anterior surface upward.
Maximum load, breaking load, elastic load, and bending
energy were obtained.Table 3 Effects of Alpinia officinarum Hance on bone mineral d
rats.
Parameter SHAM OVX
Femur BMD (g/mm2) 0.28  0.01 0.25
Femur BMC (g) 0.40  0.02 0.37
Lumbar BMD (g/mm2) 0.27  0.02 0.24
Lumbar BMC (g) 0.106  0.011 0.09
Data are presented as mean  standard deviation.
*p < 0.05 versus SHAM.
**p < 0.05 versus ovariectomised as evaluated by analysis of variance
SHAMZ rats that underwent bilateral sham operation; OVXZ rats tha
rats that underwent bilateral ovariectomy and treated with epimediu
and treated with Alpinia officinarum Hance; BMD Z bone mineral deHistology and TUNEL assay
Light femurs were removed and bone marrow cavities were
exposed using a Low Speed Saw (Buehler Ltd.), then fixed in
10% buffered formalin for 24 hours, followed by 75%
alcohol, ethylenediaminetetraacetic acid-phosphate-
buffered saline (PBS) solution, gradient alcohol dehydra-
tion, defatted by xylene, embedded in paraffin, cut at a
thickness of 3 mm with RM2155 hard tissue microtome
(Leica AG, Wetzlar, Germany), and then stained with
haematoxylin-eosin, TUNEL, and 40,6-diamidino-2-
phenylindole. The dyeing results were photographed using
a fluorescence microscope. The number of fat cavitation
and cell apoptosis were observed and compared.
Culture of rat osteoblasts
Rat osteoblasts (ROB) were isolated enzymatically from
newborn rat calvariae as described in our previous litera-
ture [42]. Briefly, newborn rats were immersed in 75%
alcohol for sterilisation, and then calvarias were isolated
and cut into small pieces. Bone fragments were exposed to
a solution containing trypsin for 15 minutes, followed by
type I collagen enzyme for 1 hour. Cells were maintained in
25-cm2 flasks in Dulbecco’s modified Eagle’s medium
(Gibco, Carlsbad, CA, USA), supplemented with 100 U/mL
penicillin, 100 mg/mL streptomycin, and 10% foetal bovine
serum (Gibco) at 37C in a humidified incubator with 5%
CO2. The medium was changed every 3 days.ensity and bone mineral content of femurs in ovariectomised
EF AOH
 0.02* 0.26  0.01* 0.26  0.08*,**
 0.03* 0.37  0.02* 0.38  0.03
 0.01* 0.25  0.01* 0.24  0.02*
 0.01* 0.09  0.01* 0.09  0.01*
.
t underwent bilateral ovariectomy and treated with vehicle; EFZ
m flavonoids; AOH Z rats that underwent bilateral ovariectomy
nsity; BMC Z bone mineral content.
80Cell viability
ROB were cultured in a 96-well plate at 6  103 cells/well
and maintained in growth medium for 24 hours at 5% CO2 at
37C. After incubation with the different treatments above
for 24 hours, 48 hours, or 72 hours, 10 mL of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) medium (5 mg/mL) were added to each well. MTT
mediums were replaced with 150 mL of solubilisation solu-
tion dimethyl sulfoxide after being cultured for an addi-
tional 4 hours, then vibrated slightly for 5 minutes. The
value of optical density of each well was recorded at a
wavelength of 570 nm using a microplate reader (Thermo
Fisher Scientific, Vantaa, Finland).Alkaline phosphatase activity
After 24 hours cultured in growth medium, ROB were
treated with AOH, five fractions (F1eF5), or galangin with
or without H2O2 in the osteogenic medium containing 10 mM
b-glycerophosphate and 50 mg/mL ascorbic acid. Cells in
96-well plates cultured for 5 days, 7 days, or 9 days, were
washed twice with 50 mM PBS (pH 7.4) and kept in 0.1%
TritonX-100 lysis buffer overnight. Disodium 4-nitrophenyl
phosphate buffer (6.7 mmol/L disodium p-nitro-
phenylphosphate hexahydrate, 25 mmol/L diethanolamine,
and 1 mmol/L MgCl2) was added in after cell thawing. NaOH
was then added to terminate the reaction and the optical
density was measured at a wavelength of 405 nm using a
microplate reader (Thermo Fisher Scientific).Alizarin red S stain
ROB were seeded in a 12-well plate and cultured for
24 hours, then treated with AOH, five fractions (F1eF5), or
galangin with or without H2O2 in the osteogenic medium
containing 10 mM b-glycerophosphate and 50 mg/mL
ascorbic acid. The mediums were changed every 3 days.
After 18 days, the cells were washed with PBS and fixed
with 95% ice-cold alcohol for 15 minutes. The cells were
then washed with PBS again, followed by 0.5% Alizarin Red S
stain (pH Z 4) for 30 minutes and subsequently washed
three times with tap water. Pictures were taken using a
Canon camera.Analysis of apoptosis
Morphological alterations of apoptotic cells were observed
using Hochest 33258 staining. Briefly, cells were cultured at
1.5  105 cells/well in a 6-well plate. After being treated
with AOH (105 g/mL), five fractions (F1eF5, 105 g/mL),
and galangin (105 g/mL) with or without H2O2 (90 mM) for
24 hours, cells were washed with PBS and fixed with 4%
paraformaldehyde for 10 minutes, followed by staining for
15 minutes with Hochest 33258 (20 mM). Cells stained
positive were photographed using a fluorescence micro-
scope (Canon, Beijing, China).Detection of intracellular reactive oxygen species
level
To determine the level of reactive oxygen species (ROS) in
H2O2-treated cells, osteoblastic cells were collected by
trypsin digestion and resuspended in serum-free culture
medium containing 10 mM 20,7’-dichlorfluorescein-diacetate
for 30 minutes at 37C. Subsequently, cells were washed
with serum-free medium to remove free probes. The cells
were then treated with vehicle control (control), H2O2
(100 mM), galangin (105 g/mL, positive control), F1
(105 g/mL), F3 (105 g/mL), or F4 (105 g/mL) for 30 mi-
nutes, followed by measurement of fluorescence intensity
using BD FACSCalibur flow cytometry. Data were analysed
and acquired using CellQuest Pro software (BD Biosciences).
Statistical analysis
Data were presented as mean  standard deviation, and
analysed using SPSS version 12.0 software for windows (SPSS
Inc., Chicago, IL, USA). The statistical differences among
groups were evaluated using variance with Fisher’s pro-
tected least significant difference test. A p value < 0.05
was chosen to indicate significance.
Results
Compositional analysis of galangin from AOH and
five fractions (F1eF5)
To determine the galangin content in each extract, AOH
and five fractions were determined using HPLC and galangin
served as a control sample. The HPLC fingerprint analysis of
the extracts is shown in Figure 1. The peak of galangin
appeared when the retention time was 13.3 minutes. From
the average peak areas of replicate injections, the content
of galangin was calculated in AOH and the five fractions. As
shown in Table 1, AOH, F2, F3, and F4 contained more
galangin than F1 and F5. AOH, F1, F2, F3, F4, and F5 con-
tained galangin of 0.519%, 0.092%, 0.384%, 24.443%,
0.191%, and 0.042% respectively.
Body and uterine weights
As shown in Figure 2, four groups of rats had a similar initial
mean body weight. The body weight of the OVX group was
significantly increased compared with the SHAM group
(p < 0.05) on Week 4 after operation, and continued to be
significantly higher throughout the study (p < 0.05). AOH
and EF can significantly prevent the OVX-induced body
weight gain at different scales from the beginning of the
2nd week (p < 0.05). OVX caused significant atrophy of
uterine tissue compared with the SHAM group (p < 0.05),
while AOH and EF did not elicit any uterotrophic effect.
Serum and bone biochemical markers of oxidative
stress
As shown in Table 2, compared with the SHAM group, serum
SOD and bone GSR were significant decreased (p < 0.05),
Table 4 Effects of Alpinia officinarum Hance on bone parameters as measured by micro-computed tomography at the
proximal femur in ovariectomised rats.
Parameter SHAM OVX EF AOH
Tb.N (1/mm) 5.28  0.43 1.03  0.18* 1.51  0.33* 1.64  0.27*,**
Tb.Th (mm) 0.12  0.01 0.09  0.01* 0.09  0.01* 0.09  0.01*
Tb.Sp (mm) 0.17  0.02 1.06  0.18* 0.74  0.14* 0.67  0.10*,**
BV/TV 0.44  0.07 0.10  0.03* 0.16  0.04* 0.17  0.02*,**
Conn.D (1/mm3) 105.71  15.68 28.05  11.40* 39.77  10.40*,** 45.51  5.59*,**
SMI 0.01  0.65 2.02  0.29* 1.74  0.37* 1.72  0.13*
Ct.Ar (mm2) 6.84  1.01 6.60  1.12 5.96  0.95 6.61  0.96
Ct.Th (mm) 1.72  0.13 1.66  0.21 1.70  0.10 1.70  0.13
Data are presented as mean  standard deviation.
*p < 0.05 versus SHAM.
**p < 0.05 versus ovariectomised rats as evaluated by analysis of variance.
SHAMZ rats that underwent bilateral sham operation; OVXZ rats that underwent bilateral ovariectomy and treated with vehicle; EFZ
rats that underwent bilateral ovariectomy and treated with epimedium flavonoids; AOH Z rats that underwent bilateral ovariectomy
and treated with Alpinia officinarum Hance; Tb.N Z trabecula number; Tb.Th Z trabecula thickness; Tb.Sp Z trabecula separation;
BV/TV Z relative bone volume to total volume; Conn.D Z connectivity density; SMI Z structure model index; Ct.Ar Z cortical area;
Ct.Th Z cortical thickness.
Figure 3 Micro-computed tomography (Viva CT40) scanning the architecture of trabecula bone and cortical bone within the
distal metaphyseal region: (A) the whole bone; (B) the cancellous bone; (C) the cortical bone. SHAM Z rats that underwent
bilateral sham operation; OVX Z rats that underwent bilateral ovariectomy and treated with vehicle; EF Z rats that underwent
bilateral ovariectomy and treated with epimedium flavonoids; AOHZ rats that underwent bilateral ovariectomy and treated with
Alpinia officinarum Hance.
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Table 5 Effects of Alpinia officinarum Hance on proximal tibial metaphysis bone structure histomorphometry in ovariec-
tomised rats (mean  standard deviation).
Parameter SHAM OVX EF AOH
Tb.Ar (%) 30.02  5.14 9.98  4.89* 12.42  3.10* 13.75  5.23*
Tb.N (#/mm) 5.81  0.79 2.11  0.95* 2.52  0.52* 2.98  1.07*,**
Tb.Sp (mm) 123.20  24.89 526.25  267.01* 361.82  85.45* 317.19  92.26*,**
Ob.Pm (%) 0.84  0.14 1.98  0.64* 1.38  0.95 1.37  0.60
Oc.N (#/mm) 1.67  0.37 3.61  1.61* 2.54  0.55* 1.87  0.64**
Oc.Pm (%) 0.29  0.07 0.50  0.27* 0.56  0.14* 0.30  0.10**
L.Pm (%) 12.66  3.12 21.09  6.72* 18.40  8.82 16.43  4.77
BFR/BS (mm/d  100) 8.69  2.18 20.78  8.23* 15.00  5.44 14.09  5.78**
Data are presented as mean  standard deviation.
*p < 0.05 versus SHAM.
**p < 0.05 versus ovariectomised rats as evaluated by analysis of variance.
SHAMZ rats that underwent bilateral sham operation; OVXZ rats that underwent bilateral ovariectomy and treated with vehicle; EFZ
rats that underwent bilateral ovariectomy and treated with epimedium flavonoids; AOH Z rats that underwent bilateral ovariectomy
and treated with Alpinia officinarum Hance; Tb.ArZ trabecular bone area; Tb.NZ trabecula number; #Z number; Tb.SpZ trabecula
separation; Ob.Pm Z osteoblasts perimeter; Oc.N Z number of osteoclasts; Oc.Pm Z osteoclasts perimeter; L.Pm Z labelled
perimeter; BFR/BS Z bone formation rate per bone surface.
82whereas serum MDA and bone ROS increased (p < 0.05) in
the OVX group. Compared with the OVX group, serum SOD
and bone GSR were significantly increased (p < 0.05), while
serum MDA and bone ROS were significantly decreased
(p < 0.05) in the AOH group and the EF group.Figure 4 Effects of Alpinia officinarum Hance (AOH) on osteobl
aphysis in ovariectomised rats: (A) toluidine blue staining (  400, o
(  400, osteoclasts: yellow arrows); (C) fluorescence (  100, do
were active in the OVX group, whereas most of the osteoblasts an
fluorescence labelling was obvious in the OVX group, while it was d
bilateral sham operation; OVX Z rats that underwent bilateral ova
bilateral ovariectomy and treated with epimedium flavonoids; AOH
Alpinia officinarum Hance.BMD
As shown in Table 3, compared with the SHAM group, a
significant reduction in BMD of the femur by 10.7%
(p < 0.05) and lumbar by 8.9% (p < 0.05) was observed in
the OVX group. Compared with the OVX group, the ratsasts, osteoclasts, and fluorescence in the proximal tibial met-
steoblasts: red arrows); (B) MassoneGoldner trichrome staining
uble fluorescence: purple arrows). Osteoblasts and osteoclasts
d osteoclasts were inactive in the AOH and EF groups. Double
imming in the AOH and EF groups. SHAMZ rats that underwent
riectomy and treated with vehicle; EF Z rats that underwent
Z rats that underwent bilateral ovariectomy and treated with
Figure 5 Effects of Alpinia officinarum Hance on bone biomechanical properties in femurs in ovariectomised rats. Values are
mean  standard error of the mean. *p < 0.05, versus SHAM. **p < 0.05 versus ovariectomised rats as evaluated by analysis of
variance.
SHAMZ rats that underwent bilateral sham operation; OVXZ rats that underwent bilateral ovariectomy and treated with vehicle;
EF Z rats that underwent bilateral ovariectomy and treated with epimedium flavonoids; AOH Z rats that underwent bilateral
ovariectomy and treated with Alpinia officinarum Hance.
Antiosteoporotic effects of Alpinia Officinarum 83treated with AOH showed a significant increase in BMD of
the femur by 4.8% (p < 0.05), while the BMD of the lumbar
showed no significant change. The rats treated with EF also
showed no significant change in the femur and lumbar
compared with the OVX group. Compared with the SHAMFigure 6 Effects of Alpinia officinarum Hance (AOH) on the num
ovariectomised rats: (A)  40; and (B)  100. SHAM Z rats that un
bilateral ovariectomy and treated with vehicle; EF Z rats that u
flavonoids; AOH Z rats that underwent bilateral ovariectomy andgroup, a significant reduction (p < 0.05) in BMC of the
femur by 10.2% (p < 0.05) and lumbar by 11.4% (p < 0.05)
was observed in the OVX rats. However, there were no
differences in femur and lumbar BMC in all treatment
groups.ber of the fat cavitation in the proximal femoral metaphysis in
derwent bilateral sham operation; OVX Z rats that underwent
nderwent bilateral ovariectomy and treated with epimedium
treated with Alpinia officinarum Hance.
Figure 7 Effects of Alpinia officinarum Hance (AOH) on cell apoptosis in the proximal femoral metaphysis in ovariectomised rats:
(A) terminal deoxynucleotidyl transferase dUTP nick end labeling staining (  40); (B) 40,6-diamidino-2-phenylindole staining
(  40); (C) A and B merged. The number of cell apoptosis events was increased in the ovariectomised group. SHAM Z rats that
underwent bilateral sham operation; OVX Z rats that underwent bilateral ovariectomy and treated with vehicle; EF Z rats that
underwent bilateral ovariectomy and treated with epimedium flavonoids; AOH Z rats that underwent bilateral ovariectomy and
treated with Alpinia officinarum Hance.
Figure 8 Effects of five fractions (F1eF5) isolated from
Alpinia officinarum Hance on the viability of primary rat os-
teoblasts. Osteoblasts were treated with concentrations
ranging from 108 g/mL to 104 g/mL of galangin, Alpinia
officinarum Hance, or the five fractions (F1eF5) for 24 hours.
Cell viability was measured by 3-(4,5)-dimethylthiahiazo (-z-
y1)-3,5-di- phenytetra zoliumromide (MTT) assay. Data are
given as mean  standard deviation of at least three inde-
pendent experiments. Data are expressed as a percentage of
control. *p < 0.05 versus control. AOH Z Alpinia officinarum
Hance.
84Bone microarchitecture
As shown in Table 4 and Figure 3, three-dimensional images
of femoral metaphysis showed significant difference in
trabecular microarchitecture between the SHAM and OVX
groups. Briefly, compared with the SHAM group, BV/TV,
Tb.N, and Tb.Th were significantly decreased by 76.0%
(p < 0.05), 80.5% (p < 0.05), and 21.0% (p < 0.05),
respectively, while Tb.Sp, Conn.D, and SMI in the proximal
femur were significantly increased by 73.5% (p < 0.05) and
12,930.0% (p < 0.05) in the OVX group. Compared with the
OVX group, BV/TV, Tb.N, and Conn.D were significantly
increased by 59.6% (p < 0.05), 59.6% (p < 0.05), and 62.2%
(p < 0.05) in the AOH group (p < 0.05), respectively, while
Tb.Sp was significantly decreased by 36.3% in the AOH
group (p < 0.05), and SMI showed no significant change in
the AOH group (p > 0.05). Compared with the OVX group,
BV/TV, Tb.N, Tb.Th, SMI, and Tb.Sp showed no significant
change, while Conn.D was significantly increased by 53.4%
in the EF group (p < 0.05). Furthermore, there were no
significant changes in Ct.Ar and Ct.Th among all groups.
Bone histomorphometry
Static and dynamic histomorphometric measurements of
the proximal tibia are illustrated in Table 5 and Figure 4.
When compared with the SHAM group, Tb.N and %Tb.Ar
were significantly decreased by 63.7% (p < 0.05) and 66.7%
(p < 0.05), while Tb.Sp, %Ob.Pm, %Oc.Pm, Oc.N, BFR/BS,and %L.Pm were significant increased, respectively, by
327.2% (p < 0.05),136.5% (p < 0.05), 71.1% (p < 0.05),
116.5% (p < 0.05), 138.9% (p < 0.05), and 66.6% (p < 0.05)
in the OVX group. Compared with the OVX group, Tb.N was
Figure 9 Effects of five fractions (F1eF5) isolated from
Alpinia officinarum Hance on the differentiation of primary rat
osteoblasts. Alkaline phosphatase activity (measured by opti-
cal density value) was determined after exposure to galangin,
Alpinia officinarum Hance, or five fractions (F1eF5) for a
period of 5 days (A), 7 days (B), and 9 days (C). ALPZ alkaline
phosphatase; AOH Z Alpinia officinarum Hance.
Antiosteoporotic effects of Alpinia Officinarum 85significantly increased by 41.1% (p < 0.05), while Tb.Sp,
Oc.N, %Oc.Pm, and BFR/BS were significantly increased by
39.7% (p < 0.05), 48.3% (p < 0.05), 39.7% (p < 0.05), and
32.2% (p < 0.05) in the AOH group, respectively. Compared
with the OVX group, static and dynamic histomorphometric
measurements of the proximal tibia had no significant
change in the EF group.
Bone biomechanical properties
As shown in Figure 5, compared with the SHAM rats, elastic
load and bending energy were significantly decreased by
12.9% (p < 0.05) and 20.7% (p < 0.05), respectively, and
maximum load and breaking load showed no significant
decrease (p > 0.05) in OVX group rats. Compared with the
OVX rats, the rats treated with AOH significantly increased
(p < 0.05) in maximum load, breaking load, and bending
energy by 7.8% (p < 0.05), 7.6% (p < 0.05), and 27.9%
(p < 0.05), respectively, but with no significant increase
(p > 0.05) in elastic load. No significant difference was
found between the OVX and EF groups.
Cells apoptosis and fat cavitation of bone marrow
As shown in Figures 6 and 7, compared with the SHAM
group, there were more numbers of fat cavitation and cell
apoptosis in the OVX group in the proximal femoral meta-
physis. Whereas compared with the OVX group, the number
of fat cavitation and cell apoptosis events were decreased
in the AOH and EF groups.
Effects of five fractions (F1eF5) isolated from AOH
on osteoblast viability
As shown in Figure 8, an increase in viability was observed
in cells treated with AOH at the concentration of 107 g/mL
to 105 g/mL. Osteoblasts treated with F3 and F4 at a
concentration from 108 g/mL to 105 g/mL showed a
distinct trend towards elevation in a concentration-
dependent manner, while at concentrations up to 104 g/
mL showing an inhibitory effect on cell proliferation.
However, osteoblasts treated with F1, F2, and F5 showed
no significant alterations at all concentrations indicated. In
particular, galangin as a positive control showed no effect
on cell viability at 24 hours, while cell viability showed a
distinct trend towards an increase in a time-dependent
manner at different time points from 24 hours, 48 hours,
to 72 hours in cells treated with 105 g/mL galangin (data
not shown).
Effects of five fractions (F1eF5) isolated from AOH
on osteoblast alkaline phosphatase activity
As shown in Figure 9, alkaline phosphatase (ALP) activity in
primary osteoblasts exposed to galangin, AOH, F3, and F4 at
concentrations of 108 g/mL to 105 g/mL remarkable
increased, while ALP activities in F1, F2, and F5 groups have
no alterations during the experimental period indicated
above. Interestingly, the effects of galangin reached the
climax of ALP activity at 7 days for an approximate 150%higher than vehicle control and lasted 9 days, while the
effect of AOH and F3 on ALP activities were driven over
150% higher than the vehicle control at 5 days and trended
towards a reduction at 9 days. Moreover, the effect of F4
exhibited no change at 5 days, but exhibited an extraordi-
nary trend increase at 9 days and reached a peak approxi-
mately 125% higher than the vehicle control.Effects of five fractions (F1eF5) isolated from AOH
on osteoblast calcification
Mineralised capacity in primary osteoblasts stimulated with
AOH and five fractions (F1eF5) was detected with Alizarin
Red S staining assay after 18 days. As shown in Figure 10,
Figure 10 Dose-dependent effects of galangin, Alpinia officinarum Hance, and five fractions (F1eF5) on rat osteoblasts min-
eralisation. Cells were cultured in osteogenic medium containing 10 mM L-glycerophosphate and 50 mg/mL ascorbic acid in the
presence or absence of indicated drugs. Mineralisation activity was stained using alizarin red S after 18 days of treatment.
AOH Z Alpinia officinarum Hance.
86galangin, AOH, F3, and F4 markedly promoted mineralised
nodules formation at the concentration of 107 g/mL to
105 g/mL when compared with the control. Meanwhile, no
stimulated effects were observed in osteoblastic cells
treated with F1, F2, and F5 compared with the control.
Collectively, according to the evidence of cell viability,
ALP activity assay, and osteoblast calcification, AOH, F3,
and F4 were selected for further study in subsequent
experiments.Effects of F3 and F4 isolated from AOH on primary
osteoblasts viability treated with oxidative stress
To elucidate the proper concentration of H2O2 on cell
viability, MTT assay was used in primary osteoblasts
viability. Osteoblast cells were treated with H2O2 ranging
from 10 mM to 100 mM for a period of 24 hours. As shown in
Figure 11A, the lower concentration (60 mM) showed no
effect on cell growth, while the higher concentration
Figure 11 Protective effects of galangin, Alpinia officinarum
Hance, F3, and F4 against H2O2-induced cell injury in rat os-
teoblasts. (A) Cell viability was measured by 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay in
osteoblasts exposed to H2O2 at the indicated concentration for
24 hours. (B) Osteoblasts were pretreated in the presence or
absence of Alpinia officinarum Hance, F3, F4, or galangin for 1
hour before the addition of H2O2 (90 mM) and were cultured for
24 hours. AOH Z Alpinia officinarum Hance.
Antiosteoporotic effects of Alpinia Officinarum 87(70 mM) showed an apparent trend in inhibitory action.
Being treated with 90 mM H2O2 exhibited an approximate
one half decrease, therefore, H2O2 at the concentration of
90 mM was used for following experiment.
To further investigate the protective effects of AOH, F3,
and F4 on rat osteoblasts against H2O2 damage, we cultured
cells in the presence of 90 mM H2O2 with or without treat-
ment of AOH, F3, F4, or galangin at the concentration ofFigure 12 Alpinia officinarum Hance, F3, F4, or galangin
compete H2O2 induced cell injury on osteoblastic differentia-
tion. Cells were pretreated with or without Alpinia officinarum
Hance, F3, F4, or galangin before the addition of H2O2 (90 mM).
Alkaline phosphatase activity was detected at Day 7. *p < 0.05
versus control. **p < 0.05 versus H2O2 (90 mM). ALP Z alkaline
phosphatase; AOH Z Alpinia officinarum Hance.108 g/mL to 104 g/mL. As shown in Figure 11B, treatment
with H2O2 (90 mM) contributed to suppression of cell
viability, which could be hindered markedly by AOH, F3, F4,
or galangin (108 g/mL to 105 g/mL) in a dose-dependent
manner, reaching a climax high at a concentration of
105 g/mL. Based on the previous evidence, AOH, F3, and
F4 with a concentration of 105 g/mL were adopted to
further study in the subsequent measurements.
Effects of F3 and F4 isolated from AOH on cell ALP
activity treated with oxidative stress
Primary osteoblasts exposed to H2O2 were cocultured with
galangin, AOH, F3, and F4 for 5 days, 7 days, and 9 days for
detecting alterations of ALP activity. As shown in Figure 12,
H2O2 (90 mM) was found to have an inhibitory effect on ALP
activity in rat osteoblasts, which was reversed by treatment
with 105 g/mL of AOH, F3, or F4, as effectively as
galangin.
Effects of F3 and F4 isolated from AOH on
osteoblast nodule formation treated with oxidative
stress
As shown in Figure 13, the extent of Alizarin Red S staining
declined dramatically in primary osteoblasts exposed to
H2O2, while the antagonistic effect of H2O2 on mineralisa-
tion was markedly rescued by AOH, F3, or F4, and espe-
cially by AOH group.
Effects of F3 and F4 isolated from AOH on ROS
production induced by oxidative stress
As shown in Figure 14, the results showed that incubation
with 90 mM H2O2 markedly increased intracellular ROS
levels, and addition of AOH, F3, and F4 at a concentration
of 105 g/mL significantly attenuated ROS production.
Compared with the control group, H2O2 (90 mM) showed an
increase in ROS level by 20%. Compared to the H2O2 group,
galangin, AOH, F3, and F4 demonstrated a decrease in ROS
level by 15%, 22.3%, 16.7%, and 3.3%, respectively. These
results revealed that AOH, F3, and F4 abated H2O2-induced
oxidative stress by scavenging ROS generation in
osteoblasts.
Effects of F3 and F4 isolated from AOH on ROB
apoptosis by oxidative stress
As shown in Figure 15, apoptotic cells characterised by
chromatin condensation, apoptotic bodies, and nuclear
fragments were observed in ROB treated with H2O2 (90 mM).
Coincubation with AOH, F3, or F4 in osteoblastic cells can
significant reduce the apoptotic extent elicited by H2O2.
Discussion
Our study, for the first time, has demonstrated the bene-
ficial effects of AOH against osteopenia in OVX rats and five
fractions of AOH containing different content of flavonoids
(i.e., galangin) on the differentiation and antioxidative
Figure 13 Alpinia officinarum Hance, F3, F4, or galangin attenuate H2O2 induced cell mineral formation injury on osteoblastic
mineralisation. AOH Z Alpinia officinarum Hance.
88activities in osteoblasts in vitro. The major findings of the
present study are as follows: (1) treatment with total
extract of AOH partially prevented bone loss, significantly
improved bone microarchitecture, bone strength, and
oxidative stress status in OVX-induced osteoporotic rats; (2)Figure 14 Coincubation with Alpinia officinarum Hance, F3, F4,
production after induction of oxidative stress. AOH Z Alpinia offi
diacetate-fluorescein isothiocyanate.in addition, AOH exerted a better effect on osteopenia
related to the decrease of osteclast surface and bone
turnover rate in OVX rats than that of epimedium flavo-
noids; (3) AOH, F3, F4, and galangin can rescue the dele-
terious impacts of oxidative stress on osteoblasticor galangin and H2O2 (90 mM) reduces reactive oxygen species
cinarum Hance; DCFH-DA-FITC Z dichloro-dihydro-fluorescein
Figure 15 Alpinia officinarum Hance, F3, F4, or galangin
counteract inhibitory effect on H2O2-induced cell apoptosis in
rat osteoblasts. Cell apoptosis was detected by Hochest 33258
staining in cells treated with Con, H, H þ G, H þ Alpinia offi-
cinarum Hance, H þ F3, and H þ F4 for 24 hours. Arrows
identify cells with condensed or fragmented nuclei, charac-
teristic of apoptosis. *p < 0.05 versus control. **p < 0.05 versus
H2O2 (90 mM). Con Z vehicle control; HZ H2O2 (90 mM);
H þ GZ H2O2 (90 mM) þ galangin (105 g/mL); H þ AOHZ H2O2
(90 mM) þ Alpinia officinarum Hance (105 g/mL);
H þ F3Z H2O2 (90 mM) þ F3 (105 g/mL); H þ F4Z H2O2
(90 mM) þ F4 (105 g/mL).
Antiosteoporotic effects of Alpinia Officinarum 89differentiation; however, F1, F2, and F5 have no effect on
promoting osteoblastic differentiation. It is indicated that
the protective effect in OVX rats and in osteoblast differ-
entiation in vitro could be partly related to higher galangin
content within AOH. Taken together, these results suggest
that AOH can be developed as a potential and promising
agent for the prevention and treatment of osteoporosis.
In this study, we found that AOH has an excellent value
in reversing bone loss of the femur evidenced by a signifi-
cant increase in BMD, BV/TV, and Tb.Th, and a decrease in
Tb.Sp, indicating that AOH could increase bone mass.
Furthermore, bone histomorphometry results demon-
strated that treatment with AOH could partially prevent
osteopenia and decrease bone turnover induced by ovari-
ectomy. AOH significantly increased %Tb.Th, while clearly
decreased Tb.Sp, %Oc.Pm, Oc.N, and BFR/BS of the tibia.
Performing a three-point bending tests on femoral diaph-
ysis, we found that AOH prevented bending energy de-
creases in OVX rats and increased maximum and fracture
force, indicating that AOH could improve bone biome-
chanical properties. Many studies have found thatflavonoids isolated from AOH consist mainly of quercetin,
kaempferol, and galangin which can promote osteoblasts
differentiation and inhibit osteoclastogenesis via down-
regulation of mRNA expression of the RANKL gene in oste-
oblasts and subsequently inhibit osteoclastic function
[21,26]. Those effects of AOH were similar to that of EF,
which additional studies have confirmed. However, as a
reference compound, the reported dose of EF cannot show
an achievement effect over AOH. Moreover, AOH signifi-
cantly decreased the number of fat cavitation and cell
apoptosis in the proximal femoral metaphysis in OVX rats
and showed better effects than EF. Taken together, these
results suggest that the antiosteoporosis effects of AOH
relate not only to flavonoids, but also to diarylheptance and
volatile oil.
To further explore the underlying mechanisms of the
protection effect of AOH and to understand the biochem-
istry relative to the effect of AOH, five fractions (F1eF5)
were isolated from AOH and treatment of their capacity of
osteoblast differentiation and mineralisation. The data
demonstrated that five fractions (F1eF5) and AOH with the
concentration ranging from 104 g/mL to 108 g/mL for
24 hours, 48 hours, and 72 hours showed no cytotoxicity in
rat osteoblastic cells. However, AOH, F3, and F4 stimulated
osteoblastic proliferation, differentiation, and mineralisa-
tion. By contrast, osteoblasts treated with F1, F2, and F5
exhibited no actions on osteoblastic development
compared with the vehicle control. The studies indicated
that AOH, F3, and F4 could be the most potent composi-
tions in the present study, protecting osteoblasts against
cell apoptosis induced by OVX. As shown in our results, F3
and F4 both contain higher amounts of galangin than F1 and
F5. Therefore, we speculate that the effect of different
fractions of AOH on osteoblastic differentiation could be
highly related to the effects of galangin. AOH works better
than F3, while it contains lower amounts of galangin than
F3, it is likely to have other substances that play a role.
Further research is required to address and expand the
present findings.
Another finding is that AOH could suppress the increase
in the weight of the OVX rats and cannot restore the atro-
phic uterus. It suggests that AOH may prevent bone loss by
other mechanisms rather than influencing oestrogen levels.
At present, oxidative stress has been considered increas-
ingly as an important risk factor of age-associated diseases
including osteoporosis [43]. Generally, excessive ROS
accumulation cannot be efficiently scavenged by an anti-
oxidant defence system, contributing to oxidative stress
and subsequently to bone loss [44]. Epidemiological evi-
dence has demonstrated that antioxidants exert a protec-
tive effect on the development of osteoporosis [45]. Based
on well-documented evidence highlighting the role of
oxidative stress in osteoporosis, we investigated firstly that
the fractions extracted from AOH showed a strong antiox-
idant effect responsible for the protection of osteoblastic
differentiation. Therefore, we investigated the protective
effects of AOH to OVX-induced oxidative damage in rats and
the different fractions (F1eF5) from AOH on H2O2-induced
oxidative damage in primary osteoblasts. In an in vivo
study, there were significant reductions in SOD and GSR
levels, improvement in bone marrow cell apoptosis and
pimelosis, but increments in MDA and ROS levels of
90ovariectomised rats compared with baseline rats. These
results are consistent with a previous study [46] which
found that OVX rats had a clear reduction in SOD enzyme.
Although treatment with AOH significantly reduced SOD and
GSR levels, and improved the bone marrow cell apoptosis
and pimelosis, it increased MDA and ROS levels of ovariec-
tomised rats. In an in vivo study, we found that H2O2 could
provoke the increase of ROS generation and subsequently
results in a decrease in cell viability, differentiation, min-
eralisation, and apoptosis, which is consistent with previous
studies [47,48]. AOH, F3, and F4 counteracted the inhibi-
tory effect of H2O2-induced oxidative stress on osteoblasts
apoptosis, differentiation, mineralisation, and ROS gener-
ation. These results strongly support the viewpoint that
AOH could scavenge ROS and subsequently attenuate
oxidative stress in vitro and in vivo.
AOH is extensively used in food flavouring and as an anti-
inflammatory agent for musculoskeletal diseases, including
rheumatism, in Chinese and Ayurvedic medicine for >2500
years [49,50]. Relevant clinical research results found that
AOH extract had a statistically significant effect on
reducing symptoms of osteoarthritis of the knee with a
good safety profile and just mild gastrointestinal adverse
events [51]. All these pieces of evidence prove the safety of
the clinical application of AOH.
In summary, the present study demonstrates that AOH
significantly partially reversed ovariectomised bone loss by
increasing bone formation and suppressing bone resorption
associated with antioxidant effects, which suggests that
AOH can be developed as a promising agent for the pre-
vention and treatment of osteoporosis. Further studies are
desirable to explore the active ingredients, mechanisms of
AOH on osteoclasts and other animal models of osteopo-
rosis, the pharmaceutical preparation, and the toxicity of
its preparation, to provide preclinical evidence for the
prevention of osteoporosis for its clinical application in the
future.
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